Table of Contents Author Guidelines Submit a Manuscript
Tuberculosis Research and Treatment
Volume 2016, Article ID 3404860, 5 pages
http://dx.doi.org/10.1155/2016/3404860
Research Article

Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United States

Centers for Disease Control and Prevention, Atlanta, GA 30329-4027, USA

Received 7 April 2016; Accepted 15 May 2016

Academic Editor: Isamu Sugawara

Copyright © 2016 Mitchell A. Yakrus et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Centers for Disease Control and Prevention, “Tuberculosis trends—United States, 2014,” Morbidity and Mortality Weekly Report, vol. 64, no. 6, pp. 264–269, 2014. View at Google Scholar
  2. Centers for Disease Control and Prevention, “Treatment of tuberculosis,” Morbidity and Mortality Weekly Report, vol. 52, pp. 1–77, 2003. View at Google Scholar
  3. J. A. Caminero, G. Sotgiu, A. Zumla, and G. B. Migliori, “Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis,” The Lancet Infectious Diseases, vol. 10, no. 9, pp. 621–629, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. Partners in Health, “The PIH Guide to the Medical Management of Multidrug-Resistant Tuberculosis,” 2014, http://parthealth.3cdn.net/b0233c0e1e4088e07b_unm6vyf2f.pdf.
  5. K. Takayama and J. O. Kilburn, “Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis,” Antimicrobial Agents and Chemotherapy, vol. 33, no. 9, pp. 1493–1499, 1989. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Mikusova, R. A. Slayden, G. S. Besra, and P. J. Brennan, “Biogenesis of the mycobacterial cell wall and the site of action of ethambutol,” Antimicrobial Agents and Chemotherapy, vol. 39, no. 11, pp. 2484–2489, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Telenti, W. J. Philipp, S. Sreevatsan et al., “The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol,” Nature Medicine, vol. 3, no. 5, pp. 567–570, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. A. M. Starks, A. Gumusboga, B. B. Plikaytis, T. M. Shinnick, and J. E. Posey, “Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 3, pp. 1061–1066, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Plinke, H. S. Cox, N. Zarkua et al., “embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation,” Journal of Antimicrobial Chemotherapy, vol. 65, no. 7, pp. 1359–1367, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Brossier, W. Sougakoff, C. Bernard et al., “Molecular analysis of the embCAB locus and embR gene involved in ethambutol resistance in clinical isolates of Mycobacterium tuberculosis in France,” Antimicrobial Agents and Chemotherapy, vol. 59, no. 8, pp. 4800–4808, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Shi, J. Zhang, K. Otomo, G. Zhang, and I. Sugawara, “Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 12, pp. 4515–4517, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Brossier, N. Veziris, A. Aubry, V. Jarlier, and W. Sougakoff, “Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates,” Journal of Clinical Microbiology, vol. 48, no. 5, pp. 1683–1689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. P. J. Campbell, G. P. Morlock, R. D. Sikes et al., “Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 5, pp. 2032–2041, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. S. V. Ramaswamy, A. G. Amin, S. Göksel et al., “Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 2, pp. 326–336, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Madison, B. Robinson-Dunn, I. George et al., “Multicenter evaluation of ethambutol susceptibility testing of Mycobacterium tuberculosis by agar proportion and radiometric methods,” Journal of Clinical Microbiology, vol. 40, no. 11, pp. 3976–3979, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Krüüner, M. D. Yates, and F. A. Drobniewski, “Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis,” Journal of Clinical Microbiology, vol. 44, no. 3, pp. 811–818, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. Zhang, Y. Wang, Y. Pang, and K. M. Kam, “Ethambutol resistance as determined by broth dilution method correlates better than sequencing results with embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates,” Journal of Clinical Microbiology, vol. 52, no. 2, pp. 638–641, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Banu, S. M. M. Rahman, M. S. R. Khan et al., “Discordance across several methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a single laboratory,” Journal of Clinical Microbiology, vol. 52, no. 1, pp. 156–163, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Christianson, D. Voth, J. Wolfe, and M. K. Sharma, “Re-evaluation of the critical concentration for ethambutol antimicrobial sensitivity testing on the MGIT 960,” PLoS ONE, vol. 9, no. 9, Article ID e108911, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Plinke, K. Walter, S. Aly, S. Ehlers, and S. Niemann, “Mycobacterium tuberculosisembB codon 306 mutations confer moderately increased resistance to ethambutol In vitro and In vivo,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 6, pp. 2891–2896, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. Centers for Disease Control and Prevention, Molecular Detection of Drug Resistance Request Form, 2013, http://www.cdc.gov/tb/topic/laboratory/MDDRsubmission form.pdf.
  22. J. Driscoll, A. Lentz, D. Sikes, and B. Metchock, “The first month of a new diagnostic service for the molecular detection of MDR and XDR tuberculosis,” American Journal of Respiratory and Critical Care Medicine, vol. 181, Article ID A2259, 2010. View at Google Scholar
  23. M. A. Yakrus, J. Driscoll, A. J. Lentz et al., “Concordance between molecular and phenotypic testing of Mycobacterium tuberculosis complex isolates for resistance to rifampin and isoniazid in the United States,” Journal of Clinical Microbiology, vol. 52, no. 6, pp. 1932–1937, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. SnapSurveys, Version Snap 10 Professional, SnapSurveys, Portsmouth, NH, USA, 2009.
  25. Clinical and Laboratory Standards Institute, “Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard,” CLSI Document M24A2E, Clinical and Laboratory Standards Institute (CLSI), Wayne, Pa, USA, 2011. View at Google Scholar
  26. F. Alcaide, G. E. Pfyffer, and A. Telenti, “Role of embB in natural and acquired resistance to ethambutol in mycobacteria,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 10, pp. 2270–2273, 1997. View at Google Scholar · View at Scopus
  27. F. Ardito, B. Posteraro, M. Sanguinetti, S. Zanetti, and G. Fadda, “Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis,” Journal of Clinical Microbiology, vol. 39, no. 12, pp. 4440–4444, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Cambau, M. Viveiros, D. Machado et al., “Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study,” Journal of Antimicrobial Chemotherapy, vol. 70, no. 3, Article ID dku438, pp. 686–696, 2015. View at Publisher · View at Google Scholar · View at Scopus